Oxybutynin for hot flashes in men on androgen-deprivation therapy: interpreting the Alliance A222001 trial. [PDF]
Greenstein A +3 more
europepmc +1 more source
Management of cardiometabolic risk in prostate cancer: expert consensus from Singapore and Malaysia. [PDF]
Chen K +11 more
europepmc +1 more source
Bone-related adverse events of hormonal therapy: A pharmacovigilance study based on the Food & Drug Administration Adverse Event Reporting System. [PDF]
Wang Y, Li A, Wang J, Xie M.
europepmc +1 more source
Purpose: Numerous studies have produced conflicting findings regarding the efficacy of statins in prostate cancer treatment. Our objective was to examine the correlation between statin usage and clinical outcomes in Taiwanese men with de novo ...
Tzu Shuang Chen +9 more
doaj +1 more source
Recent advances in hormone-based biopharmaceuticals for cancer therapy. [PDF]
Sarifulnazwan SN +11 more
europepmc +1 more source
Lipid Mediators as Therapeutic Targets in Prostate Cancer. [PDF]
Balijepalli P, Meier KE.
europepmc +1 more source
Do Platelets Explain Why GnRH Antagonists Are Potentially Safer From a Cardiovascular Perspective? [PDF]
Deng Y, Wang Y, Cheng L.
europepmc +1 more source
Effective Control of Synchronous Male Breast and Prostate Cancer with Androgen Deprivation Therapy: A Case Report. [PDF]
Furukawa M +12 more
europepmc +1 more source
Mechanisms, Impact, and Clinical Management of Cancer-Related Anorexia: A Narrative Review. [PDF]
Fang X, Wang X, Qian X.
europepmc +1 more source
Indian Delphi consensus on cardiovascular risk mitigation in prostate cancer management. [PDF]
Bakshi G +20 more
europepmc +1 more source

